PCR fluorescence

PCR manawa maoli Multiplex | ʻenehana piʻo hoʻoheheʻe | Pololei | ʻŌnaehana UNG | Reagent wai a me ka lyophilized

PCR fluorescence

  • 18 ʻAno o ka Human Papilloma Virus Kiʻekiʻe-pilikia (16/18 Typing) Pahu ʻIke Waikawa Nucleic (Fluorescence PCR)

    18 ʻAno o ka Human Papilloma Virus Kiʻekiʻe-pilikia (16/18 Typing) Pahu ʻIke Waikawa Nucleic (Fluorescence PCR)

    Kōmike Huahana

    HWTS-CC018B

    ʻAe ʻia ka huahana

    CE, TFDA

    Hoʻohana i manaʻo ʻia

    He kūpono kēia pahu hana no ka ʻike ʻana i nā ʻano maʻi papilloma kanaka he 18 (HPV) (HPV16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, 82) o nā ʻāpana waikawa nucleic kikoʻī i loko o nā laʻana mimi kanaka, nā laʻana swab cervical wahine, nā laʻana swab vaginal wahine a me ke ʻano HPV 16/18.

  • ʻEiwa ʻAno o ka Maʻi Genitourinary Tract Pathogen Nucleic Acid Detection Kit (Fluorescence PCR)

    ʻEiwa ʻAno o ka Maʻi Genitourinary Tract Pathogen Nucleic Acid Detection Kit (Fluorescence PCR)

    [Inoa Huahana]ʻEiwa ʻAno o ka Genitourinary Tract Infection Pathogen Nucleic Acid Detection Kit

    (PCR fluorescence)

    [HuahanaKōkuhi]HWTS-UR048

    [Manaʻo Hoʻohana]

    He kūpono kēia pahu hana no ka ʻike ʻana i ka qualitative in vitro o Chlamydia trachomatis (CT),Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes Simplex Virus Type1 (HSV1), Ureaplasma urealyticum, UU), ʻAno Maʻi Herpes Simplex 2 (HSV2),Ureaplasma Parvum (UP), Mycoplasma genitalium (Mg), Trichomonal vaginitis (TV)i loko o ka mimi, ka ʻauʻau urethral kāne, ka ʻauʻau cervical wahine, a me nā hāpana ʻauʻau vaginal wahine,e hāʻawi i ke kōkua no ka ʻike ʻana a me ka mālama ʻana i nā maʻi me ka ʻōnaehana genitourinaryka maʻi ʻana.

  • 28 ʻAno o ka Human Papillomavirus (16/18/45Typing) Pahu ʻIke Waikawa Nucleic (Fluorescence PCR)

    28 ʻAno o ka Human Papillomavirus (16/18/45Typing) Pahu ʻIke Waikawa Nucleic (Fluorescence PCR)

    [HuahanaKōkuhi]HWTS-CC024

    [Manaʻo Hoʻohana]

    He kūpono kēia pahu no ka ʻike ʻana i ka qualitative in vitro o 28 mau ʻano o ka human papillomavirus (HPV 6, 11, 16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 54, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83) nā waikawa nucleic i loko o ka laʻana mimi lapaʻau, ka laʻana swab cervical wahine a me ka laʻana swab vaginal wahine, a me ka ʻike ʻana i ke ʻano HPV 16/18/45, ʻoiai ʻaʻole hiki ke hoʻokaʻawale loa ʻia nā ʻano i koe, e hāʻawi ana i ke kōkua i ka ʻike ʻana a me ka mālama ʻana i ka maʻi HPV.

  • Pahu ʻike waikawa nukleika Nipah Virus (Fluorescence PCR)

    Pahu ʻike waikawa nukleika Nipah Virus (Fluorescence PCR)

    Hoʻohana ʻia kēia huahana no ka ʻike qualitative in vitro o ka Nipah virus nucleic acid i loko o nā oropharyngeal swabs, nasopharyngeal swabs, cerebrospinal fluid, serum, a me nā laʻana mimi.
  • Pahu ʻIke Helu HIV-1 (Fluorescence PCR)

    Pahu ʻIke Helu HIV-1 (Fluorescence PCR)

    Hoʻohana ʻia ka HIV-1 Quantitative Detection Kit (Fluorescence PCR) (i kapa ʻia ma hope aku ʻo ke kit) no ka ʻike ʻana i ka nui o ka human immunodeficiency virus type I RNA i loko o nā laʻana serum a i ʻole plasma, a hiki ke nānā i ka pae o ka maʻi HIV-1 i loko o nā laʻana serum a i ʻole plasma.

  • ʻAkika Nukleika Bacillus Anthracis

    ʻAkika Nukleika Bacillus Anthracis

    Hoʻohana ʻia kēia pahu no ka ʻike ʻana i ka qualitative o ka bacillus anthracis nucleic acid i loko o nā hāpana koko o nā mea maʻi me ka maʻi bacillus anthracis i manaʻo ʻia ma vitro.

  • ʻO ka waikawa nukleika ʻo Francisella Tularensis

    ʻO ka waikawa nukleika ʻo Francisella Tularensis

    He kūpono kēia pahu hana no ka ʻike ʻana i ka qualitative o ka francisella tularensis nucleic acid i loko o ke koko, ka wai lymph, nā isolates i hoʻoulu ʻia a me nā specimens ʻē aʻe in vitro.

  • ʻO ka waikawa nukleika Yersinia Pestis

    ʻO ka waikawa nukleika Yersinia Pestis

    Hoʻohana ʻia kēia pahu hana no ka ʻike qualitative o ka Yersinia pestis nucleic acid i loko o nā hāpana koko.

  • ʻO ka waikawa nukleika Orientia tsutsugamushi

    ʻO ka waikawa nukleika Orientia tsutsugamushi

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka qualitative o ka nucleic acid o Orientia tsutsugamushi i loko o nā laʻana serum.

  • ʻO ka waikawa nukleika o ka maʻi West Nile

    ʻO ka waikawa nukleika o ka maʻi West Nile

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka waikawa nucleic virus West Nile i loko o nā hāpana serum.

  • ʻO ka waikawa nucleic Zaire a me Sudan Ebolavirus i hoʻomaloʻo ʻia

    ʻO ka waikawa nucleic Zaire a me Sudan Ebolavirus i hoʻomaloʻo ʻia

    He kūpono kēia pahu no ka ʻike ʻana i ka waikawa nucleic Ebolavirus i loko o nā laʻana serum a plasma paha o nā maʻi i manaʻo ʻia he maʻi Zaire ebolavirus (EBOV-Z) a me Sudan ebolavirus (EBOV-S), e hoʻomaopopo ana i ka ʻike ʻana i ke ʻano.

  • ʻO ka maʻi Encephalitis B Nucleic Acid

    ʻO ka maʻi Encephalitis B Nucleic Acid

    Hoʻohana ʻia kēia pahu hana no ka ʻike ʻana i ka maʻi encephalitis B i loko o ke koko a me ka plasma o nā mea maʻi in vitro.

123456Aʻe >>> ʻAoʻao 1 / 12